Cancer Research Targets  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 9107, October 1, 2007. doi: 10.1158/0008-5472.CAN-07-0869
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hitchins, M. P.
Right arrow Articles by Ward, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hitchins, M. P.
Right arrow Articles by Ward, R. L.

Molecular Biology, Pathobiology, and Genetics

Epigenetic Inactivation of a Cluster of Genes Flanking MLH1 in Microsatellite-Unstable Colorectal Cancer

Megan P. Hitchins1,5, Vita Ap Lin1, Andrew Buckle1, Kayfong Cheong1, Nimita Halani1, Su Ku1, Chau-To Kwok1, Deborah Packham1, Catherine M. Suter3, Alan Meagher2, Clare Stirzaker4, Susan Clark4, Nicholas J. Hawkins6 and Robyn L. Ward1,5

Departments of 1 Medical Oncology and 2 Colorectal Surgery, St. Vincent's Hospital; 3 Victor Chang Cardiac Research Centre; 4 Garvan Institute of Medical Research, Darlinghurst, Australia; and 5 School of Medicine, 6 School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia

Requests for reprints: Robyn Ward, Department of Medical Oncology, St. Vincent's Hospital, Victoria Street, Darlinghurst, New South Wales 2010, Australia. Phone: 61-29295-8412; Fax: 61-28382-3386; E-mail: Robyn{at}unsw.edu.au.

Biallelic promoter methylation and transcriptional silencing of the MLH1 gene occurs in the majority of sporadic colorectal cancers exhibiting microsatellite instability due to defective DNA mismatch repair. Long-range epigenetic silencing of contiguous genes has been found on chromosome 2q14 in colorectal cancer. We hypothesized that epigenetic silencing of MLH1 could occur on a regional scale affecting additional genes within 3p22, rather than as a focal event. We studied the levels of CpG island methylation and expression of multiple contiguous genes across a 4 Mb segment of 3p22 including MLH1 in microsatellite-unstable and -stable cancers, and their paired normal colonic mucosa. We found concordant CpG island hypermethylation, H3-K9 dimethylation and transcriptional silencing of MLH1 and multiple flanking genes spanning up to 2.4 Mb in microsatellite-unstable colorectal cancers. This region was interspersed with unmethylated genes, which were also transcriptionally repressed. Expression of both methylated and unmethylated genes was reactivated by methyltransferase and histone deacetylase inhibitors in a microsatellite-unstable colorectal carcinoma cell line. Two genes at the telomeric end of the region were also hypermethylated in microsatellite-stable cancers, adenomas, and at low levels in normal colonic mucosa from older individuals. Thus, the cluster of genes flanking MLH1 that was specifically methylated in the microsatellite-unstable group of cancers extended across 1.1 Mb. Our results show that coordinate epigenetic silencing extends across a large chromosomal region encompassing MLH1 in microsatellite-unstable colorectal cancers. Simultaneous epigenetic silencing of this cluster of 3p22 genes may contribute to the development or progression of this type of cancer. [Cancer Res 2007;67(19):9107–16]




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Novak, T. J. Jensen, J. C. Garbe, M. R. Stampfer, and B. W. Futscher
Stepwise DNA Methylation Changes Are Linked to Escape from Defined Proliferation Barriers and Mammary Epithelial Cell Immortalization
Cancer Res., June 15, 2009; 69(12): 5251 - 5258.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Derks, L. J.W. Bosch, H. E.C. Niessen, P. T.M. Moerkerk, S. M. van den Bosch, B. Carvalho, S. Mongera, J.W. Voncken, G. A. Meijer, A. P. de Bruine, et al.
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21
Carcinogenesis, June 1, 2009; 30(6): 1041 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Rodriguez, M. Munoz, L. Vives, C. G. Frangou, M. Groudine, and M. A. Peinado
Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells
PNAS, December 16, 2008; 105(50): 19809 - 19814.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Novak, T. Jensen, M. M. Oshiro, G. S. Watts, C. J. Kim, and B. W. Futscher
Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer
Cancer Res., October 15, 2008; 68(20): 8616 - 8625.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
P. Karpinski, D. Ramsey, Z. Grzebieniak, M. M. Sasiadek, and N. Blin
The CpG Island Methylator Phenotype Correlates with Long-Range Epigenetic Silencing in Colorectal Cancer
Mol. Cancer Res., April 1, 2008; 6(4): 585 - 591.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.